Related Experiment Video
Updated: Jul 25, 2026

Derivation of Glial Restricted Precursors from E13 mice
Published on: June 20, 2012
Iopanoic acid in the management of neonatal Graves' disease
Sonja M Earles1, Peter M Gerrits, David J Transue
1Department of Pediatrics, William Beaumont Hospital, Royal Oak, MI 48073, USA.
Insights
Iopanoic acid offers a safe and effective treatment for neonatal thyrotoxicosis, significantly improving infant health. This novel approach reduces the need for frequent dosing and avoids the side effects associated with traditional therapies.
Area of Science:
- Endocrinology
- Neonatal Medicine
- Pharmacology
Background:
- Neonatal thyrotoxicosis is traditionally managed with antithyroid drugs, iodine, sedatives, and propranolol.
- Conventional treatments for neonatal thyrotoxicosis carry risks of side effects and require frequent administration.
Purpose of the Study:
- To evaluate the efficacy and safety of using the radio-contrast agent iopanoic acid for managing neonatal thyrotoxicosis.
Main Methods:
- Five infants diagnosed with neonatal thyrotoxicosis were treated.
- Initial treatment involved propranolol (1.7 mg/kg/day) combined with iopanoic acid (250-500 mg every 3-4 days).
Main Results:
- All infants showed significant clinical improvement within 24-72 hours.
- Thyroid hormone levels (T3 and T4) decreased dramatically.
- No adverse toxic side effects were observed during the treatment period.
Conclusions:
- Iopanoic acid provides a successful management strategy for neonatal thyrotoxicosis.
- This treatment is well-tolerated, requires infrequent dosing (every 3-4 days), and maintains euthyroid status without inducing hypothyroidism.
- Iopanoic acid presents a safer alternative to propylthiouracil (PTU), which has significant side effects and requires more frequent administration.
Objective:
Traditionally, neonatal thyrotoxicosis has been managed with antithyroid drugs and/or iodine as well as sedatives, propranol and digitalis when necessary. The purpose of this study was to evaluate the management of neonatal thyrotoxicosis using the radio-contrast agent iopanoic acid.
Methods:
We managed five cases of neonatal thyrotoxicosis. All infants were treated initially with propranolol (1.7 mg/kg/day) and iopanoic acid 250 to 500 mg every third or fourth day.
Results:
In all cases, clinical signs improved and T(3) and T(4) levels decreased dramatically within 24 to 72 hours. No toxic side effects were noted.
Conclusion:
Neonatal thyrotoxicosis can be managed successfully using iopanoic acid. Iopanoic acid is essentially free of side effects and need only be administered every 3 to 4 days. When administered until (transplacental) maternal TSI has been metabolized by the neonate, iopanoic acid maintains euthyroid status with no risk of hypothyroidism. With conventional therapy, propylthiouracil (PTU) must be administered three times a day. PTU also carries a significant risk of toxic side effects and a week or more of therapy is required to correct the hyperthyroid state and may induce hypothyroidism.
More Related Videos
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Drug Dosing: Infants and Children
Pharmaceutical Poisoning: Treatment Strategies
Acute Kidney Injury VI: Nursing Management
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology

